132 related articles for article (PubMed ID: 34647945)
1. Anti-glioblastoma effects of nanomicelle-curcumin plus erlotinib.
Bagherian A; Roudi B; Masoudian N; Mirzaei H
Food Funct; 2021 Nov; 12(21):10926-10937. PubMed ID: 34647945
[TBL] [Abstract][Full Text] [Related]
2. Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways.
Bagherian A; Mardani R; Roudi B; Taghizadeh M; Banfshe HR; Ghaderi A; Davoodvandi A; Shamollaghamsari S; Hamblin MR; Mirzaei H
J Mol Neurosci; 2020 Oct; 70(10):1471-1483. PubMed ID: 32666415
[TBL] [Abstract][Full Text] [Related]
3. Effect of curcumin on glioblastoma cells.
Hesari A; Rezaei M; Rezaei M; Dashtiahangar M; Fathi M; Rad JG; Momeni F; Avan A; Ghasemi F
J Cell Physiol; 2019 Jul; 234(7):10281-10288. PubMed ID: 30585634
[TBL] [Abstract][Full Text] [Related]
4. Study on the Inhibitory Effect of Curcumin on GBM and Its Potential Mechanism.
Su X; Chen S; Lu H; Li H; Qin C
Drug Des Devel Ther; 2021; 15():2769-2781. PubMed ID: 34234410
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells.
Liu S; Tang Y; Yuan X; Yuan D; Liu J; Li B; Li Y
Invest New Drugs; 2018 Dec; 36(6):961-969. PubMed ID: 29508248
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
7. Curcumin mediated down-regulation of α
Javadi S; Rostamizadeh K; Hejazi J; Parsa M; Fathi M
Phytother Res; 2018 Feb; 32(2):355-364. PubMed ID: 29168312
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-functionalized gelatin hydrogels reveal extracellular matrix signals temper the efficacy of erlotinib against patient-derived glioblastoma specimens.
Pedron S; Wolter GL; Chen JE; Laken SE; Sarkaria JN; Harley BAC
Biomaterials; 2019 Oct; 219():119371. PubMed ID: 31352310
[TBL] [Abstract][Full Text] [Related]
9. Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform.
Mesbahi Y; Zekri A; Ahmadian S; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Eur J Pharmacol; 2018 Feb; 820():274-285. PubMed ID: 29274334
[TBL] [Abstract][Full Text] [Related]
10. Crizotinib and erlotinib inhibits growth of c-Met
Goodwin CR; Rath P; Oyinlade O; Lopez H; Mughal S; Xia S; Li Y; Kaur H; Zhou X; Ahmed AK; Ho S; Olivi A; Lal B
Clin Neurol Neurosurg; 2018 Aug; 171():26-33. PubMed ID: 29803091
[TBL] [Abstract][Full Text] [Related]
11. Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death.
Eimer S; Belaud-Rotureau MA; Airiau K; Jeanneteau M; Laharanne E; Véron N; Vital A; Loiseau H; Merlio JP; Belloc F
Cancer Biol Ther; 2011 Jun; 11(12):1017-27. PubMed ID: 21508666
[TBL] [Abstract][Full Text] [Related]
12. Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition.
Liffers K; Kolbe K; Westphal M; Lamszus K; Schulte A
Target Oncol; 2016 Feb; 11(1):29-40. PubMed ID: 26032687
[TBL] [Abstract][Full Text] [Related]
13. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol.
Meng L; Chu X; Xing H; Liu X; Xin X; Chen L; Jin M; Guan Y; Huang W; Gao Z
Int J Pharm; 2019 Aug; 567():118485. PubMed ID: 31260781
[TBL] [Abstract][Full Text] [Related]
14. Demethoxycurcumin Suppresses Proliferation, Migration, and Invasion of Human Brain Glioblastoma Multiforme GBM 8401 Cells
Su RY; Hsueh SC; Chen CY; Hsu MJ; Lu HF; Peng SF; Chen PY; Lien JC; Chen YL; Chueh FS; Chung JG; Yeh MY; Huang YP
Anticancer Res; 2021 Apr; 41(4):1859-1870. PubMed ID: 33813391
[TBL] [Abstract][Full Text] [Related]
15. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.
Gersey ZC; Rodriguez GA; Barbarite E; Sanchez A; Walters WM; Ohaeto KC; Komotar RJ; Graham RM
BMC Cancer; 2017 Feb; 17(1):99. PubMed ID: 28160777
[TBL] [Abstract][Full Text] [Related]
16. Curcumin enhances the radiosensitivity of U87 cells by inducing DUSP-2 up-regulation.
Qian Y; Ma J; Guo X; Sun J; Yu Y; Cao B; Zhang L; Ding X; Huang J; Shao JF
Cell Physiol Biochem; 2015; 35(4):1381-93. PubMed ID: 25792385
[TBL] [Abstract][Full Text] [Related]
17. Folate-PEG/Hyd-curcumin/C18-g-PSI micelles for site specific delivery of curcumin to colon cancer cells via Wnt/β-catenin signaling pathway.
Le TT; Kim D
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():464-471. PubMed ID: 31029341
[TBL] [Abstract][Full Text] [Related]
18. Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma.
Wu H; Liu Q; Cai T; Chen YD; Wang ZF
Mol Med Rep; 2015 Oct; 12(4):5461-6. PubMed ID: 26239619
[TBL] [Abstract][Full Text] [Related]
19. The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma.
Zanotto-Filho A; Braganhol E; Edelweiss MI; Behr GA; Zanin R; Schröder R; Simões-Pires A; Battastini AM; Moreira JC
J Nutr Biochem; 2012 Jun; 23(6):591-601. PubMed ID: 21775121
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-7 Replacement Effect on Proliferation and Tarceva-Sensitivity in U373-MG Cell Line.
Alamdari-Palangi V; Karami Z; Karami H; Baazm M
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1747-1753. PubMed ID: 32592373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
